• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶液型定量吸入气雾剂的喷雾射流与药物沉积的相关性。

Correlation Between Dynamic Spray Plume and Drug Deposition of Solution-Based Pressurized Metered-Dose Inhalers.

机构信息

Shanghai Sine Pharmaceutical Laboratories Co. Ltd., Shanghai, China.

出版信息

J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):232-240. doi: 10.1089/jamp.2023.0050. Epub 2024 Jul 15.

DOI:10.1089/jamp.2023.0050
PMID:39007176
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11502628/
Abstract

The lack of visual dynamic spray characterization has made the understanding of the physical processes governing atomization and drug particle formation difficult. This study aimed to investigate the changes in the spray plume morphology and aerodynamic particle size of solution-based pressurized metered-dose inhalers (pMDIs) under different conditions to achieve better drug deposition. Solution-based pMDIs were studied, and the effects of various factors, such as propellant concentration, orifice diameters, and atomization chamber volume, on drug deposition were examined by analyzing the characteristics of spray plume and aerodynamic particle size. Reducing the actuator orifice and spray area led to a concentrated spray plume and increased duration and speed. Moreover, the aerodynamic particle sizes D50 and D90 decreased, whereas D10 remained relatively unchanged. Decreasing the atomization chamber volume of the actuator led to reduced spray area and an increased duration but a decreased plume velocity. D90 exhibited a decreasing trend, whereas D10 and D50 remained relatively unchanged. Reducing the propellant concentration in the prescription, the spray area and the plume velocity first decreased and then increased. The duration initially increased and then decreased. The values of D50 and D90 showed an initial decreasing followed by an increasing trend, whereas D10 remained relatively unchanged. During the development process, attention should be paid to the changes in the spray area, spray angle, duration, and speed of the spray plume. This study recommended analyzing the characteristics of the spray plume and combining the data of two or more aerodynamic particle size detection methods to verify the deposition to achieve rapid screening and obtain high lung deposition .

摘要

缺乏可视化动态喷雾特性研究使得人们难以理解控制雾化和药物颗粒形成的物理过程。本研究旨在探讨不同条件下溶液型定量吸入气雾剂(pMDI)喷雾羽流形态和空气动力学粒径的变化,以实现更好的药物沉积。研究了溶液型 pMDI,并通过分析喷雾羽流和空气动力学粒径的特性,考察了推进剂浓度、喷嘴直径和雾化腔体积等各种因素对药物沉积的影响。减小致动器喷嘴和喷雾区域会导致喷雾羽流更加集中,喷雾持续时间和速度增加。此外,空气动力学粒径 D50 和 D90 减小,而 D10 相对不变。减小致动器雾化腔体积会导致喷雾区域减小,喷雾持续时间增加,但喷雾羽流速度降低。D90 呈下降趋势,而 D10 和 D50 相对不变。降低处方中的推进剂浓度,喷雾区域和羽流速度先减小后增大。喷雾持续时间先增加后减小。D50 和 D90 的值先减小后增大,而 D10 相对不变。在开发过程中,应注意喷雾区域、喷雾角度、喷雾羽流持续时间和速度的变化。本研究建议分析喷雾羽流的特性,并结合两种或更多空气动力学粒径检测方法的数据,以验证沉积情况,实现快速筛选并获得高肺部沉积。

相似文献

1
Correlation Between Dynamic Spray Plume and Drug Deposition of Solution-Based Pressurized Metered-Dose Inhalers.溶液型定量吸入气雾剂的喷雾射流与药物沉积的相关性。
J Aerosol Med Pulm Drug Deliv. 2024 Oct;37(5):232-240. doi: 10.1089/jamp.2023.0050. Epub 2024 Jul 15.
2
The Role of Low Global Warming Potential Propellants on Suspension Metered Dose Inhaler Sprays.低全球变暖潜能值推进剂在混悬型定量吸入气雾剂喷雾中的作用
AAPS PharmSciTech. 2025 Jun 2;26(5):154. doi: 10.1208/s12249-025-03147-y.
3
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
4
Comparison of Formoterol, Glycopyrrolate, and Beclomethasone Dipropionate Pharmacokinetic Profile after Inhaled Administration as pMDI Using HFA134a or HFA152a Propellant: Preclinical Assessment of Drug Exposure in Sprague-Dawley Rat Model.使用HFA134a或HFA152a推进剂以压力定量吸入气雾剂(pMDI)吸入给药后福莫特罗、格隆溴铵和丙酸倍氯米松药代动力学特征的比较:在Sprague-Dawley大鼠模型中对药物暴露的临床前评估
J Aerosol Med Pulm Drug Deliv. 2025 Feb;38(1):18-25. doi: 10.1089/jamp.2024.0019. Epub 2024 Sep 26.
5
Evaluation of a cardboard-based spacer for enhancing aerosol delivery from pressurized metered dose inhalers.一种用于增强定量压力气雾剂雾化给药效果的纸质储雾罐的评估
J Asthma. 2025 Jul;62(7):1141-1147. doi: 10.1080/02770903.2025.2463965. Epub 2025 Feb 12.
6
Spray pattern analysis for metered dose inhalers: effect of actuator design.定量吸入器的喷雾模式分析:促动器设计的影响。
Pharm Res. 2006 Jul;23(7):1591-6. doi: 10.1007/s11095-006-0280-z. Epub 2006 Jun 21.
7
Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion.不同吸入装置在慢性阻塞性肺疾病患者中的肺部沉积率和吸气流量:系统文献回顾和专家意见。
Int J Chron Obstruct Pulmon Dis. 2021 Apr 19;16:1021-1033. doi: 10.2147/COPD.S297980. eCollection 2021.
8
Physiologically Based Biopharmaceutic Lung Deposition Modeling to Guide Clinical Device Transition of Protein A from a Nebulizer to a Dry Powder Inhaler.基于生理学的生物药剂学肺部沉积建模,以指导蛋白A从雾化器向干粉吸入器的临床器械转换
Mol Pharm. 2025 Jul 7;22(7):3693-3701. doi: 10.1021/acs.molpharmaceut.4c01387. Epub 2025 Jun 25.
9
Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.Respimat软雾吸入器与压力定量吸入器的气雾剂速度和喷雾持续时间比较。
J Aerosol Med. 2005 Fall;18(3):273-82. doi: 10.1089/jam.2005.18.273.
10
Small Airways Disease Affects Aerosol Deposition in Children with Severe Asthma: A Functional Respiratory Imaging Study.小气道疾病影响重度哮喘儿童的气溶胶沉积:一项功能性呼吸成像研究。
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):351-361. doi: 10.1089/jamp.2024.0005. Epub 2024 Sep 4.

本文引用的文献

1
Revealing pMDI Spray Initial Conditions: Flashing, Atomisation and the Effect of Ethanol.揭示压力定量吸入器喷雾初始条件:闪蒸、雾化及乙醇的影响。
Pharm Res. 2017 Apr;34(4):718-729. doi: 10.1007/s11095-017-2098-2. Epub 2017 Jan 17.
2
Advances in metered dose inhaler technology: formulation development.定量吸入器技术进展:制剂研发
AAPS PharmSciTech. 2014 Apr;15(2):434-55. doi: 10.1208/s12249-013-0063-x. Epub 2014 Jan 23.
3
Plume temperature emitted from metered dose inhalers.定量吸入器喷出的羽流温度。
Int J Pharm. 2011 Feb 28;405(1-2):9-15. doi: 10.1016/j.ijpharm.2010.11.037. Epub 2010 Dec 1.
4
Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.在基于134a的加压定量吸入器中平衡乙醇助溶剂浓度与产品性能。
J Aerosol Med. 2003 Summer;16(2):167-74. doi: 10.1089/089426803321919924.
5
Future directions in aerosol therapy.雾化治疗的未来发展方向。
Respir Care Clin N Am. 2001 Jun;7(2):319-35, vii. doi: 10.1016/s1078-5337(05)70036-8.
6
Drug-surfactant-propellant interactions in HFA-formulations.氢氟烷烃制剂中的药物 - 表面活性剂 - 抛射剂相互作用
Int J Pharm. 1999 Sep 10;186(1):13-30. doi: 10.1016/s0378-5173(99)00134-9.
7
The inhalation device influences lung deposition and bronchodilating effect of terbutaline.吸入装置会影响特布他林的肺部沉积和支气管扩张效果。
Am J Respir Crit Care Med. 1996 May;153(5):1636-40. doi: 10.1164/ajrccm.153.5.8630614.
8
Size aspects of metered-dose inhaler aerosols.定量吸入气雾剂的粒径方面
Am Rev Respir Dis. 1985 Jul;132(1):137-42. doi: 10.1164/arrd.1985.132.1.137.